FDA Approves New DexCom Diabetes Device [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
The San Diego, Calif.-based firm said Thursday that its Dexcom G7 15 Day system had been approved by the FDA to treat people 18 and older with diabetes. It is expected to launch in the U.S. in the second half of the year. "By listening to the needs of our users, we're proud to offer the longest lasting wearable and most accurate CGM, giving people the knowledge to better control their diabetes," DexCom COO Jake Leach said. Shares of DexCom rose nearly 10% Thursday morning to lead S&P 500 gainers on a day of broad market declines but pared advances and were little changed in recent trading. They have lost more than 50% of their value over the past year. A month ago, the firm received a warning letter from the FDA over the condition of two
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. ShareholdersGlobeNewswire
- DexCom, Inc. (NASDAQ: DXCM) was upgraded by analysts at Mizuho to a "strong-buy" rating.MarketBeat
- The FDA Just Cleared the Dexcom G7 15-Day, the Longest-Lasting CGM [CNET News]CNET News
- 2 Growth Stocks to Buy in the Tariff-Fueled Market Correction [Yahoo! Finance]Yahoo! Finance
- Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 2/13/25 - Miss
DXCM
Sec Filings
- 3/31/25 - Form 3
- 3/27/25 - Form ARS
- 3/27/25 - Form DEFA14A
- DXCM's page on the SEC website